ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1105

The Impact of Vascular Access Type on the Survival and Quality of Life in Incident Hemodialysis Patients: Comparisons Among Arteriovenous Fistula, Graft, and Temporary Catheters

Session Information

  • Vascular Access - II
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 704 Dialysis: Vascular Access

Authors

  • Kim, Do Hyoung, Hallym University Hangang Sacred Heart Hospital, Seoul, Korea (the Republic of)
  • Lim, Chun Soo, Seoul National University Boramae Medical Center, Seoul, Korea (the Republic of)
Background

Arteriovenous fistula (AVF) is the preferred vascular access for haemodialysis (HD); however, the association between vascular access and quality of life (QOL) is not well-known. We investigate the relationships between HD vascular access and all-cause mortality, health-related quality of life (HRQOL) and depression in a large prospective cohort.

Methods

A total of 1461 patients for whom HD was newly initiated were prospectively enrolled. The initial vascular access types were classified as AVF, arteriovenous graft (AVG) and central venous catheter (CVC). The primary outcome was all-cause mortality and the secondary outcomes were HRQOL, depression and all-cause hospitalisation. Kidney Disease Quality of Life Short Form 36 and Beck’s depression inventory scores were measured to assess HRQOL and depression, respectively.

Results

Of 1461 patients, 314 patients started HD via AVF, 76 via AVG, and 1071 via CVC. In the survival analysis, patients with AVF or AVG showed significantly better survival than those with CVC (P=0.015). The numbers of annual hospitalisation were not different among the groups. The AVF and AVG groups had a significantly higher Kidney Disease Quality of Life Short Form 36 score and a significantly lower Beck’s depression inventory score than the CVC group at 3 months and 12 months after the initiation of dialysis.

Conclusion

Patients with AVF or AVG have a better survival and HRQOL score and are less depressed than those with CVC. These suggest that the choice of vascular access in incident HD patients is important in terms of mortality and quality of life.